ES2376239T3 - Procedimiento de cultivo de células mioc�?rdicas. - Google Patents
Procedimiento de cultivo de células mioc�?rdicas. Download PDFInfo
- Publication number
- ES2376239T3 ES2376239T3 ES04818986T ES04818986T ES2376239T3 ES 2376239 T3 ES2376239 T3 ES 2376239T3 ES 04818986 T ES04818986 T ES 04818986T ES 04818986 T ES04818986 T ES 04818986T ES 2376239 T3 ES2376239 T3 ES 2376239T3
- Authority
- ES
- Spain
- Prior art keywords
- cyclin
- protein
- gene
- cip
- cardiomyocytes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003391708 | 2003-11-21 | ||
JP2003391708 | 2003-11-21 | ||
JP2004246533 | 2004-08-26 | ||
JP2004246533 | 2004-08-26 | ||
PCT/JP2004/017274 WO2005049822A1 (ja) | 2003-11-21 | 2004-11-19 | 心筋細胞の増殖方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2376239T3 true ES2376239T3 (es) | 2012-03-12 |
Family
ID=34622192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES04818986T Active ES2376239T3 (es) | 2003-11-21 | 2004-11-19 | Procedimiento de cultivo de células mioc�?rdicas. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070009496A1 (ru) |
EP (1) | EP1693451B1 (ru) |
JP (1) | JP4809061B2 (ru) |
KR (1) | KR101169980B1 (ru) |
CN (1) | CN1882687B (ru) |
AT (1) | ATE532863T1 (ru) |
AU (1) | AU2004291809B2 (ru) |
BR (1) | BRPI0416732A (ru) |
CA (1) | CA2545049A1 (ru) |
DK (1) | DK1693451T3 (ru) |
ES (1) | ES2376239T3 (ru) |
IL (1) | IL175264A0 (ru) |
RU (1) | RU2378375C2 (ru) |
SG (1) | SG148197A1 (ru) |
WO (1) | WO2005049822A1 (ru) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090285791A1 (en) * | 2008-05-15 | 2009-11-19 | Sbarro Health Research Organization, Inc. | Regenerating and enhancing development of muscle tissue |
US20130005796A1 (en) * | 2010-03-12 | 2013-01-03 | Daiichi Sankyo Company, Limited | Method for proliferating cardiomyocytes using micro-rna |
EP2640829A4 (en) | 2010-11-17 | 2014-06-11 | Univ Kyoto | CARDIOMYOCYTE AND / OR CARDIOVORA CELL PROLIFERATING AGENTS AND METHOD FOR PROLIFERATING CARDIOMYOCYTES AND / OR CARDIOVORA CELLS |
RU2466391C1 (ru) * | 2011-03-28 | 2012-11-10 | Государственное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения и социального развития Российской Федерации (ГОУ ВПО Первый МГМУ им. И.М. Сеченова Минздравсоцразвития России) | Способ диагностики рецидивирующей кровопотери |
CA2837322C (en) | 2011-05-26 | 2023-03-21 | University Of Washington | Cell and gene based methods to improve cardiac function |
CN102382127A (zh) * | 2011-09-23 | 2012-03-21 | 复旦大学 | 特异性促进心肌细胞发生增殖的心肌小分子化合物及其应用 |
WO2014038655A1 (ja) * | 2012-09-07 | 2014-03-13 | 国立大学法人京都大学 | 腸上皮由来体性幹細胞の製造方法 |
EP3259346A4 (en) * | 2015-02-20 | 2018-07-11 | Baylor College of Medicine | P63 inactivation for the treatment of heart failure |
JP6960396B2 (ja) * | 2015-04-07 | 2021-11-05 | ザ ジェイ. デビッド グラッドストーン インスティテューツ、 ア テスタメンタリー トラスト エスタブリッシュド アンダー ザ ウィル オブ ジェイ. デビッド グラッドストーン | 分裂終了細胞の細胞分裂を誘発するための方法 |
CN110907644B (zh) * | 2019-12-11 | 2023-01-06 | 深圳市达科为生物工程有限公司 | 多种细胞鉴定试剂盒及操作方法 |
CN113061573B (zh) * | 2021-05-21 | 2023-03-24 | 苏州大学 | 间歇性饥饿促进心肌细胞成熟的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1354671A (zh) * | 1998-11-02 | 2002-06-19 | 加利福尼亚大学董事会 | 抑制受磷蛋白活性以治疗心脏病和心力衰竭的方法 |
US7795032B2 (en) * | 2001-05-17 | 2010-09-14 | Masaaki Ikeda | Methods for proliferating cardiomyocytes and recombinant vectors therefor |
US20030199464A1 (en) * | 2002-04-23 | 2003-10-23 | Silviu Itescu | Regeneration of endogenous myocardial tissue by induction of neovascularization |
-
2004
- 2004-11-19 AU AU2004291809A patent/AU2004291809B2/en not_active Ceased
- 2004-11-19 AT AT04818986T patent/ATE532863T1/de active
- 2004-11-19 CA CA002545049A patent/CA2545049A1/en not_active Abandoned
- 2004-11-19 EP EP04818986A patent/EP1693451B1/en not_active Not-in-force
- 2004-11-19 US US10/580,248 patent/US20070009496A1/en not_active Abandoned
- 2004-11-19 SG SG200808669-6A patent/SG148197A1/en unknown
- 2004-11-19 KR KR1020067009795A patent/KR101169980B1/ko not_active IP Right Cessation
- 2004-11-19 ES ES04818986T patent/ES2376239T3/es active Active
- 2004-11-19 RU RU2006121980/13A patent/RU2378375C2/ru not_active IP Right Cessation
- 2004-11-19 CN CN2004800344225A patent/CN1882687B/zh not_active Expired - Fee Related
- 2004-11-19 BR BRPI0416732-5A patent/BRPI0416732A/pt active Search and Examination
- 2004-11-19 DK DK04818986.4T patent/DK1693451T3/da active
- 2004-11-19 WO PCT/JP2004/017274 patent/WO2005049822A1/ja active Application Filing
- 2004-11-19 JP JP2005515664A patent/JP4809061B2/ja not_active Expired - Fee Related
-
2006
- 2006-04-27 IL IL175264A patent/IL175264A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2004291809B2 (en) | 2010-05-20 |
AU2004291809A1 (en) | 2005-06-02 |
EP1693451A4 (en) | 2007-11-07 |
IL175264A0 (en) | 2006-09-05 |
WO2005049822A1 (ja) | 2005-06-02 |
ATE532863T1 (de) | 2011-11-15 |
EP1693451B1 (en) | 2011-11-09 |
SG148197A1 (en) | 2008-12-31 |
US20070009496A1 (en) | 2007-01-11 |
JPWO2005049822A1 (ja) | 2007-06-07 |
CN1882687B (zh) | 2012-07-04 |
KR101169980B1 (ko) | 2012-07-31 |
KR20060125760A (ko) | 2006-12-06 |
CA2545049A1 (en) | 2005-06-02 |
RU2378375C2 (ru) | 2010-01-10 |
CN1882687A (zh) | 2006-12-20 |
DK1693451T3 (da) | 2012-02-13 |
EP1693451A1 (en) | 2006-08-23 |
RU2006121980A (ru) | 2007-12-27 |
BRPI0416732A (pt) | 2007-01-16 |
JP4809061B2 (ja) | 2011-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5795670B2 (ja) | 循環系細胞におけるpim−1活性を操作するための組成物および方法 | |
Valkov et al. | MicroRNA-1-mediated inhibition of cardiac fibroblast proliferation through targeting cyclin D2 and CDK6 | |
JP2002530436A (ja) | 増殖能を増強しかつ複製老化を防止する方法及び試薬 | |
ES2376239T3 (es) | Procedimiento de cultivo de células mioc�?rdicas. | |
JPWO2005093067A1 (ja) | シノビオリン遺伝子のプロモーターに対するデコイ核酸 | |
WO2012134478A1 (en) | Compositions and methods for the treatment and prevention of cardiac ischemic injury | |
CA3019570A1 (en) | Enhanced direct cardiac reprogramming | |
Zhou et al. | Suppression of rat Frizzled-2 attenuates hypoxia/reoxygenation-induced Ca2+ accumulation in rat H9c2 cells | |
US20130123340A1 (en) | Compositions and methods for the treatment and prevention of cardiac ischemic injury | |
Hauck et al. | p21CIP1/WAF1-dependent inhibition of cardiac hypertrophy in response to Angiotensin II involves Akt/Myc and pRb signaling | |
Hu et al. | Serinc2 deficiency exacerbates sepsis-induced cardiomyopathy by enhancing necroptosis and apoptosis | |
US7053194B2 (en) | Compositions and methods for p53-mediated repression of gene expression | |
US7795032B2 (en) | Methods for proliferating cardiomyocytes and recombinant vectors therefor | |
JP4499994B2 (ja) | 終末分化細胞の増殖方法及びそのための組換えベクター | |
US20220111013A1 (en) | Compound decreasing the concentration of 2-hydroxy-glutarate | |
CN111542334B (zh) | 用于预防或治疗心律失常的药物组合物 | |
WO2015020215A1 (ja) | レンチウイルスベクターthtd、該thtdを含有する老化剤、がん抑制剤および医薬組成物、ウイルス様中空粒子で包装されたタンパク質、並びにウイルス様中空粒子の製造方法 | |
US20090285791A1 (en) | Regenerating and enhancing development of muscle tissue | |
US20030130216A1 (en) | Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease(cad) for treating cardiac disease | |
Glembotski et al. | distribute. Destroy after use. | |
Szotek et al. | PYK2 regulates SERCA2 gene expression in neonatal | |
Yang et al. | Angiotensin Ii-Induced Upregulation of Sbk3 in Mitochondria Via Calcineurin-Nfatc3 Signalling Suppresses Hypertrophy | |
YI | C-ABL promotes osteoblast expansion through BMP signaling pathways | |
WO2007059366A2 (en) | Reagents and methods for modulating gene expression related to hypertension |